SOHM, Inc. (SHMN)
SOHM, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Corona, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1.4M. On trailing twelve-month figures it carries a trailing P/E of 9.00, a net margin of -66.6%. Its beta of 0.80 implies it has historically moved less than the broad market.
SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. It also exports its products. The company has collaboration agreement with Coastar Therapeutics to advance in the field of genome editing using red blood cell membrane derived carriers and genome editing technology. SOHM, Inc. was founded in 2005 and is based in Corona, California.
SOHM, Inc. is most often compared with the following Healthcare names: